Loading
Latest filing published 07 Jul 2026 for Rocket Pharmaceuticals, INC., €36k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Only one filing by Malik Fady Ibraham is known so far (7 July 2026): a transaction, €36k, in Rocket Pharmaceuticals, Inc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration